nodal yield as a surrogate for the quality of surgery and for comparing node counts between surgeons or between open and robotic surgery at different institutions.
INTRODUCTION AND OBJECTIVES: Survival expectancies is poor for bladder cancer (BCa) patients with disseminated disease. On the other hand, several reports showed that patients with survival in node positive patients treated with radical cystectomy (RC) is not invariably poor. However, at the time only scarce data exists about the efficacy of surgery in clinical node positive BCa patients with a limited disseminated disease.
METHODS: We evaluated a total of 192 patients with BCa and concurrent node positive disease in the pelvis. All patients were treated with RC and pelvic lymph node dissection (PLND) without neoadjuvant chemotherapy between 2001 and 2013. Adjuvant chemotherapy was offered to patients on the bases of their characteristics and physicians preferences. We analyzed concordance between clinical and pathological findings. Moreover, Kaplan Meier analyses and Cox regression analyses were used to assess the impact of this features on recurrence, cancer specific survival (CSS) and overall survival (OS) after surgery.
RESULTS: With a median follow up of 48 months, we recorded 5 year recurrence, CSS and OS of 46%, 44% and 38%, respectively. Overall, 99 patients (51.6%) where found without node metastases at RC, while 18 (9.4%), 58 (30.2%) and 17 (8.9%) patients were found pN1, pN2 and pN3, respectively. 5 year CSS survival rates were 54%, 42%, 32% and 18% for pN0, pN1, pN2 and pN3, respectively. Overall, 36 (18.8%) patients were treated with adjuvant chemotherapy. At univariable Cox regression analyses, the use of adjuvant chemotherapy was not associated with improved recurrence, CSS and OS after RC (all p>0.2). On the other hand, when only pN+ patients were considered, adjuvant chemotherapy was associated with improved OS (Hazard ratio [HR]: 0.42, confidence interval [CI]: 0.20-0.86, p¼0.02).
CONCLUSIONS: We report excellent survival outcomes in clinical node positive patients treated with RC. The use of adjuvant chemotherapy after surgery was not associated with improvement in survival expectancies in cN+ patients, on the other hand, when only pN+ patients were considered adjuvant chemotherapy showed increased overall survival expectations. Our data needs to be further evaluated in high quality prospective study. (Bca) patients. Some series reported the absence of sentinel lymph node in Bca patients, on the other hand, at the time no data supports the use of extended PLND since the data available from the randomized trial on this topic failed to assess significant survival benefit for patients treated with ePLND when compared patients trated with limited PLND. Therefore we sought to describe incidence and location of node metastases in patients treated with extended and super extended PLND highlighting its association with adverse pathologic features.
Source of
METHODS: we evaluated 653 contemporary patients with clinically non metastatic BCa treated with RC and extended or super extended pelvic lymph node dissection (PLND) at a single tertiary care referral center between 1990 and 2013. Limited PLND is defined as the removal of obturator and internal illiac nodes. Standard included also the external illiac nodes. Extended includes also common and presacral nodes. Finally super extended PLND includes all the nodes removed within inferior mesenteric artery. We evaluated incidence of pathologycaly node metastases. Moreover we describe the location of the metastases and its association with other pathologic adverse features.
RESULTS: Overall, 191 (29.3%) patients were found with pathologically node confirmed metastases. Of these, 57 (29.5%) patients were found with a single node metastases, while 136 (70.5%) had multiple node metastases. The vast majority of patients were found with node metastases in limited and standard templates only (n¼150, 23.0%), on the other hand 43 (6.6%) patients had node metastases in the extended and super extended PLND template. Only 2 patients were found with node metastases in the extended or superextended PLND template without having concomitant node metastases in the standard template. The presence of node metastases in the extendeed or super extended PLND was found higher in pT3-pT4 patients (n¼40, 93.0%) when compared to pT0-pT2 patients (n¼3, 7.0%) patients (p val-ue<0.001). On the other hand, no difference were found considering lymphovascular invasion (p¼0.4), presence of carcinoma in situ (p¼0.3), age (p¼0.7) or gender (p¼0.6).
CONCLUSIONS: We found that the majority of patients harbored node disease in the limited or standard node dissection pattern. On the other hand only a minority of patient were found with a disease in extended or super extended template without harboring a concomitant node disease in the limited pattern. Considering demographics and pathological features, only pT3-pT4 disease were associated with an increased risk of node metastases in the extended and superextended template. 
Source of Funding: none

INTRODUCTION AND OBJECTIVES:
The majority of roboticassisted renal surgery is performed via the transperitoneal route (T). Retroperitoneal robotic-assisted partial nephrectomy (R-RAPN) allows direct access to hilar structures and the posterolateral surface of the kidney. In the few comparative studies published, it has shown potential advantages. We review our institution's experience with RAPN.
METHODS: Data from all consecutive patients who underwent RAPN at our single institution between June 2010 and October 2016 were prospectively collected. Demographics, R.E.N.A.L. nephrometry e780 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
